P08183 |
MDR1_HUMAN |
Lung cancer [ICD-11: 2C25] |
P08183 |
MDR1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08183 |
MDR1_HUMAN |
Bacterial infection [ICD-11: 1A00-1C4Z] |
P08183 |
MDR1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P08183 |
MDR1_HUMAN |
Adrenal cancer [ICD-11: 2D11] |
P08183 |
MDR1_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P00533 |
EGFR_HUMAN |
Non-small cell lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P00533 |
EGFR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P00533 |
EGFR_HUMAN |
Angina pectoris [ICD-11: BA40] |
P00533 |
EGFR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P00533 |
EGFR_HUMAN |
Colon cancer [ICD-11: 2B90] |
P00533 |
EGFR_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P00533 |
EGFR_HUMAN |
Diabetic foot ulcer [ICD-11: BD54] |
P00533 |
EGFR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P00533 |
EGFR_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
P00533 |
EGFR_HUMAN |
Ischemia [ICD-11: 8B10-8B11] |
P00533 |
EGFR_HUMAN |
Liver cancer [ICD-11: 2C12] |
P00533 |
EGFR_HUMAN |
Lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Melanoma [ICD-11: 2C30] |
P00533 |
EGFR_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P00533 |
EGFR_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P00533 |
EGFR_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
P00533 |
EGFR_HUMAN |
Skin postprocedural disorder [ICD-11: EL8Y] |
P00533 |
EGFR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P00533 |
EGFR_HUMAN |
Stomach cancer [ICD-11: 2B72] |
P00533 |
EGFR_HUMAN |
Unspecific body region injury [ICD-11: ND56] |
P00533 |
EGFR_HUMAN |
Urethral cancer [ICD-11: 2C93] |
P00533 |
EGFR_HUMAN |
Brain cancer [ICD-11: 2A00] |
P00533 |
EGFR_HUMAN |
Hypopharyngeal cancer [ICD-11: 2B6D] |
P00533 |
EGFR_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P00533 |
EGFR_HUMAN |
Metastatic biliary tract neoplasms [ICD-11: 2C14-2C17] |
P00533 |
EGFR_HUMAN |
Chronic pain [ICD-11: MG30] |
P00533 |
EGFR_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P00533 |
EGFR_HUMAN |
Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y] |
P00533 |
EGFR_HUMAN |
Non-small cell lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Intracerebral haemorrhage [ICD-11: 8B00] |
P00533 |
EGFR_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P00533 |
EGFR_HUMAN |
Metastatic lymph node neoplasm [ICD-11: 2D60] |
P00533 |
EGFR_HUMAN |
Spinal cord/cranial nerve neoplasm [ICD-11: 2A02] |
P00533 |
EGFR_HUMAN |
Testicular cancer [ICD-11: 2C80] |
P00533 |
EGFR_HUMAN |
Esophageal cancer [ICD-11: 2B70] |
P00533 |
EGFR_HUMAN |
Psoriasis [ICD-11: EA90] |
P00533 |
EGFR_HUMAN |
Digestive system disease [ICD-11: DE2Z] |
P00533 |
EGFR_HUMAN |
Cerebral ischaemia [ICD-11: 8B1Z] |
P00533 |
EGFR_HUMAN |
Cryptosporidiosis [ICD-11: 1A32] |
P00533 |
EGFR_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P00533 |
EGFR_HUMAN |
Gram-positive bacterial infection [ICD-11: 1B74-1F40] |
P00533 |
EGFR_HUMAN |
Brain cancer [ICD-11: 2A00] |
P00533 |
EGFR_HUMAN |
Liver cancer [ICD-11: 2C12] |
P00533 |
EGFR_HUMAN |
Lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
P09917 |
LOX5_HUMAN |
Filariasis [ICD-11: 1F66] |
P09917 |
LOX5_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P09917 |
LOX5_HUMAN |
Lung cancer [ICD-11: 2C25] |
P09917 |
LOX5_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P09917 |
LOX5_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P09917 |
LOX5_HUMAN |
Atopic eczema [ICD-11: EA80] |
P09917 |
LOX5_HUMAN |
Carcinoid syndrome [ICD-11: 5B10] |
P09917 |
LOX5_HUMAN |
Fungal infection [ICD-11: 1F29-1F2F] |
P09917 |
LOX5_HUMAN |
Idiopathic interstitial pneumonitis [ICD-11: CB03] |
P09917 |
LOX5_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P09917 |
LOX5_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P09917 |
LOX5_HUMAN |
Psoriasis [ICD-11: EA90] |
P09917 |
LOX5_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P09917 |
LOX5_HUMAN |
Respiratory system disease [ICD-11: CB40-CB7Z] |
P09917 |
LOX5_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P09917 |
LOX5_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P09917 |
LOX5_HUMAN |
Eczema [ICD-11: EA80-EA89] |
P09917 |
LOX5_HUMAN |
Pruritus [ICD-11: EC90] |
P09917 |
LOX5_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P09917 |
LOX5_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P09917 |
LOX5_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P09917 |
LOX5_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P09917 |
LOX5_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P15559 |
NQO1_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
P15559 |
NQO1_HUMAN |
CNS anomalies syndrome [ICD-11: LD20] |
P15559 |
NQO1_HUMAN |
Inborn energy metabolism error [ICD-11: 5C53] |
P15559 |
NQO1_HUMAN |
Intellectual development disorder [ICD-11: LD90] |
P15559 |
NQO1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P15559 |
NQO1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P13726 |
TF_HUMAN |
Acute respiratory distress syndrome [ICD-11: CB00] |
P13726 |
TF_HUMAN |
Bleeding disorder [ICD-11: GA20-GA21] |
P13726 |
TF_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P13726 |
TF_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |